DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
TREATMENT PROTOCOL S-145
OPIOID WITHDRAWAL / OPIOID USE DISORDER
Date: 7/1/2025 Page 1 of 1
1 For agencies participating in the Buprenorphine Pilot Program
2 For agencies participating in the Leave Behind Naloxone Program
BLS ALS
• Ensure patent airway
• O2 saturation PRN
• O2 and/or ventilate PRN
Symptomatic suspected opioid OD with
RR <12
• Treat per Poisoning / Overdose Protocol
(S-134)
For suspected opioid withdrawal or opioid
use disorder, request for ALS to provide
treatment and transport1
For patients and/or other individuals
suspected of opioid use disorder, provide
Leave Behind Naloxone Kit with education
per the Leave Behind Naloxone Program2
• Monitor/ECG
• IV/IO Ⓐ
• Capnography
Symptomatic suspected opioid OD with respiratory depression
(RR<12, SpO2<96%, or EtCO2 ≥40 mmHg)
• Treat per Poisoning / Overdose Protocol (S-134)
Complete COWS score using S-145A1

For suspected opioid withdrawal in patients ≥16 years with
COWS score ≥81
• Contact opioid withdrawal base
• Buprenorphine-naloxone (Suboxone®) 16 mg/4 mg SL BHO
(opioid withdrawal base)
• Reassess after 15 min
• Repeat with buprenorphine-naloxone (Suboxone®) 8 mg/2 mg SL
to a max of 24 mg/6 mg
• Recommend transport to emergency department
• Ensure warm handoff
If patient declines transport:
• Verify patient contact information
• Ensure warm handoff
• Attempt to arrange non-EMS transport to appropriate facility
• Provide Leave Behind Naloxone kit and education
• Provide MAT information, coaching, and brochure
Buprenorphine Pilot Program exclusion criteria:
• Any methadone use within the last 10 days
• Lack of opioid withdrawal signs or symptoms
• Under 16 years of age
• Severe medical illness (e.g., sepsis, respiratory distress)
• Unable to give consent or comprehend potential risks and benefits for any reason, including altered mental status

